MD, PhD, MBA
Dr. David Greene, MD, PhD, MBA, stands at the forefront of regenerative medicine and healthcare innovation, blending clinical expertise with entrepreneurial vision. As the founder and CEO of R3 Stem Cell and US Lead Network, Dr. Greene has dedicated his career to advancing patient care and empowering medical practices through advanced therapies and digital marketing excellence.
A residency and fellowship-trained orthopedic surgeon, Dr. Greene began his journey in medicine with a deep commitment to helping others. After years in clinical practice, he recognized the transformative potential of regenerative therapies and the urgent need for better patient access and education. This insight led him to establish R3 Stem Cell, now a global leader in non-surgical treatment options using stem cell and PRP therapy. Under his leadership, R3 Stem Cell has performed over 26,000 procedures across more than 45 international clinics, offering hope and healing to patients worldwide.
Dr. Greene’s entrepreneurial spirit didn’t stop at clinical innovation. He also founded US Lead Network, a healthcare internet marketing company that leverages artificial intelligence to help medical and dental practices grow their patient base efficiently and ethically. His two books on healthcare internet marketing have become essential reading for providers seeking to navigate the complexities of digital patient acquisition. Recognized as a Top 20 Expert Author by Ezines.com – ranking #15 out of over 470,000 authors and #1 in Pain Management – Dr. Greene’s thought leadership has shaped the way healthcare professionals connect with patients online.
A defining moment in Dr. Greene’s career was his decision to leave clinical practice and focus entirely on innovation and education. “I’ve never been a fan of just settling for the status quo. Innovation is a cornerstone of what makes America great,” he reflects. This philosophy has driven R3 Stem Cell’s mission to provide affordable, high-quality regenerative care and to demystify stem cell therapies through comprehensive training courses and educational content for both providers and patients.
Dr. Greene’s work has garnered international recognition, including a feature on the cover of Corporate Vision magazine, where his commitment to affordable, accessible regenerative therapies was spotlighted. His impact extends beyond business metrics – he is known for his compassionate approach, always prioritizing patient education and ethical practice.
Outside of his professional life, Dr. Greene is inspired by the words of Maya Angelou: “My mission in life is not merely to survive, but to thrive; and to do so with some passion, some compassion, some humor, and some style”. He brings this ethos to his daily work, fostering a culture of innovation, empathy, and continuous learning.
When he’s not leading global healthcare initiatives, Dr. Greene enjoys sharing insights on social media, connecting with colleagues, and pursuing personal interests that keep him grounded and inspired.
Dr. David Greene’s journey is a testament to the power of combining clinical skill, business acumen, and a heartfelt commitment to making a difference – one patient, one practice, and one innovation at a time.
All Posts
Ischemic heart disease and acute myocardial infarction (heart attack) remain leading causes of morbidity and mortality worldwide. When a blockage restricts blood supply to the myocardium, oxygen deprivation causes cardiomyocytes (heart muscle cells) to die, leaving behind non-contractile scar tissue. Because the human heart has
Amyotrophic lateral sclerosis (ALS) is a progressive disease that affects the nerve cells controlling voluntary muscle movement. As motor neurons die, patients gradually lose the ability to walk, speak, swallow, and eventually breathe. Because ALS currently has no cure and few effective drug treatments, many
Exosomes, which are a type of extracellular vesicle, have become extremely popular in the United States over the past few years. There are several reasons for this, which are explained below. The top exosome distributor and supplier in the USA is ReBella Suppliers, which offers
Parkinson’s disease is a progressive neurodegenerative disorder marked by the gradual loss of dopaminergic neurons in the substantia nigra region of the brain. As dopamine levels drop, patients experience tremors, rigidity, bradykinesia (slowed movement), and postural instability. While standard pharmaceutical treatments (such as levodopa) help
Chronic exposure to cigarette smoke remains the leading cause of progressive lung conditions such as Chronic Obstructive Pulmonary Disease (COPD), pulmonary emphysema, and lung tissue fibrosis. Smoke inhalation introduces thousands of toxic chemical compounds into the respiratory tract, triggering widespread oxidative stress, tissue degradation, and
For professional athletes and active individuals, early-onset joint degeneration can feel like a career-ending diagnosis. When traditional medicine offers limited choices—such as invasive joint replacement or permanent nerve ablation—patients increasingly look toward regenerative procedures to restore function and manage pain without sacrificing their long-term mobility.
For millions of patients navigating chronic joint pain, osteoarthritis, or soft tissue injuries, selecting the right injection therapy can be overwhelming. Traditional approaches—namely corticosteroid shots and hyaluronic acid injections—have long dominated orthopedic care. However, advancing clinical research highlights clear distinctions between temporary pain suppression and
Stem cell science has produced no shortage of breakthroughs, but few discoveries have generated as much genuine excitement as Muse cells. Short for “multilineage-differentiating stress-enduring” cells, Muse cells are a naturally occurring stem cell population found in adult human tissue — no embryos, no genetic
Patients exploring regenerative medicine for tendon or ligament pain often assume any imaging method will tell their doctor everything needed. In reality, the imaging method chosen can significantly affect how accurately a problem is identified — and how effectively it can be treated. In a
Biological aging is a progressive, systemic process driven by cellular degradation, chronic inflammation, and declining tissue repair capabilities. While standard lifestyle modifications—such as maintaining a low-inflammatory diet, managing stress, engaging in regular exercise, and optimizing sleep—remain essential foundations for health, they cannot fully halt the
